At a glance
ClinicalIndex Comparison RecordN/ACompleted· 109 enrolled
Drug / intervention
magnetic resonance imaging (MRI)behavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Neurobiology of Alcohol and Nicotine Co-Addiction
In Brief
An observational study evaluating magnetic resonance imaging (MRI) for Alcohol Use Disorder and Nicotine Use Disorder. Completed, enrolled 109 participants across 1 site.
Detailed Summary
This proposal addresses the critical absence of information about the neurobiology of recovery from Alcohol Use Disorder (AUD) in alcohol and nicotine users.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAlcohol Use Disorder, Nicotine Use Disorder
CountriesUnited States
CollaboratorsOregon Health and Science University
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedNov 2017
Enrollment StartFeb 2018
Primary CompletionJan 2023
TodayJul 2026
First PostedNov 9, 2017
Enrollment StartFeb 8, 2018
Primary CompletionJan 3, 2023
TodayJul 2, 2026
Enrollment to primary: 4.9 yearsPosted 8.6 years ago
Interventions
magnetic resonance imaging (MRI)behavioral
All subjects will undergo a baseline MRI and subjects in both alcohol groups (alcohol use disorder and combined alcohol and nicotine use disorder) will undergo a followup MRI 3 months after baseline.